Clinical Trial Detail

NCT ID NCT03016741
Title Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Recruitment Recruiting
Gender male
Phase FDA approved
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications

prostate cancer

Therapies

Enzalutamide

Abiraterone + Prednisone

Age Groups: adult senior

No variant requirements are available.